1. Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads
- Author
-
Laurence M. Epstein, Donald D. Hegland, Robert K. Lewis, Sean D. Pokorney, Roger G. Carrillo, Xiaojuan Mi, Emily P. Zeitler, Melissa A. Greiner, Jonathan P. Piccini, and Sana M. Al-Khatib
- Subjects
Male ,Pacemaker, Artificial ,medicine.medical_specialty ,030204 cardiovascular system & hematology ,Medicare ,03 medical and health sciences ,0302 clinical medicine ,Physiology (medical) ,Humans ,Medicine ,In patient ,030212 general & internal medicine ,Intensive care medicine ,Lead (electronics) ,Device Removal ,Aged ,Aged, 80 and over ,business.industry ,Age Factors ,Cardiac Pacing, Artificial ,United States ,Defibrillators, Implantable ,Surgery ,Survival Rate ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Background: Lead management is an increasingly important aspect of care in patients with cardiac implantable electronic devices; however, relatively little is known about long-term outcomes after capping and abandoning leads. Methods: Using the 5% Medicare sample, we identified patients with de novo cardiac implantable electronic device implantations between January 1, 2000, and December 31, 2013, and with a subsequent lead addition or extraction ≥12 months after the de novo implantation. Patients who underwent extraction for infection were excluded. Using multivariable Cox proportional hazards models, we compared cumulative incidence of all-cause mortality, device-related infection, device revision, and lead extraction at 1 and 5 years for the extraction versus the cap and abandon group. Results: Among 6859 patients, 1113 (16.2%) underwent extraction, whereas 5746 (83.8%) underwent capping and abandonment. Extraction patients tended to be younger (median, 78 versus 79 years; P P =0.05), and had shorter lead dwell time (median, 3.0 versus 4.0 years; P P =0.027). There was no association between extraction and mortality, lead revision, or lead extraction at 5 years. Conclusions: Elective lead extraction for noninfectious indications had similar long-term survival to that for capping and abandoning leads in a Medicare population. However, extraction was associated with lower risk of device infections at 5 years.
- Published
- 2017
- Full Text
- View/download PDF